Alcidion Group Ltd (ALC) reported record annual revenue of AUD 51.6 million for the fiscal year ended June 30, 2026, a 27% increase from the prior year, as the company marked its strongest financial performance to date.
Underlying earnings before interest, tax, depreciation and amortisation rose 34% year-on-year to AUD 6.8 million, while net profit after tax increased 38% to AUD 2.3 million. The company maintained zero debt and ended the period with AUD 20.6 million in cash, following the acquisition of Kyra Flow products from Telstra Health on June 20, 2026.
Total contract value signed during the year reached a record AUD 78.5 million, including AUD 62.2 million in new or upsell agreements. Annual recurring revenue grew 34% to AUD 38.3 million, supported by the Kyra acquisition, which contributed approximately AUD 3.6 million. Services revenue increased 56% to AUD 3.5 million, while capital licence revenue totalled AUD 9.8 million at an 80% gross margin.
Geographically, revenue growth was led by the United Kingdom, which accounted for 63% of total revenue and expanded 27% year-on-year. Australia and New Zealand grew 26% to AUD 19.1 million. Management highlighted secured revenue of AUD 44.9 million entering FY2027, up 32% from the start of FY2026, with AUD 38.3 million classified as ARR.
Shares of Alcidion rose 8.05% to AUD 0.094, extending gains following the earnings update. The stock remains 35.2% below its 52-week high of AUD 0.145 and 8.1% above its low of AUD 0.082. The company’s price-to-earnings ratio stands at 56.71, with a gross profit margin of 57%.
Looking ahead, Alcidion expects FY2027 revenue and underlying EBITDA to exceed FY2026 levels, with capital licence margins projected to return to an 85% long-term average. The company is targeting expansion in Canada, the Middle East and Southeast Asia, while continuing to focus on its cloud-native Miya Precision platform and related products including Kyra Flow, Smartpage and Mosaic.
